Stay updated with breaking news from Orofacial Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Public Release: 21-Nov-2017 PLOS A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the open access journal PLOS Biology. Researchers Cristin Kearns, Dorie Apollonio and…
UCSF School of Dentistry resident Kimiya Abtahi, DDS, counts aloud while gently brushing her 11-year-old patient’s teeth. The boy, Alex, sits perfectly still while his mother, father and younger brother look on. When Abtahi reaches the count of “10,”
Researchers at UC San Francisco have engineered molecules that act like "cellular glue," allowing them to direct in precise fashion how cells bond with each other. The discovery represents a major step toward building tissues and organs, a...
Researchers engineered cells containing customized adhesion molecules that bind to specific cell partners in predictable ways to form complex multicellular entities. The discovery is a major step toward building new tissue and organs.
UC San Francisco scientists have formed a research alliance with pharmaceutical firm Eli Lilly and Company aimed at better understanding autoimmune diseases and fostering the development of new therapies. Based on the innovative Immunoprofiler model launched at UCSF in 2017, the new initiative, called AutoImmunoprofiler, inherits the most successful aspects of its predecessor and adapts them to the study of autoimmunity. Autoimmune diseases such as lupus, inflammatory bowel disease, and type 1 diabetes occur when the immune system attacks the bodyâs own tissues. While there are some ...